Best Poster Award




The Best Poster Award

PURPOSE:

The top posters presented at PharmSci 360 are selected for recognition because of the importance scientifically impactful posters have in advancing the pharmaceutical sciences. Abstracts that are selected for poster presentation at PharmSci 360 offer a key mechanism for scientists to share the recent results of their research with the scientific community. Timely communication of research can have a significant impact on the thoughts and actions of other researchers.

IDEAL RECIPIENT:

An AAPS member who is the presenting author of a top-rated poster for PharmSci 360.

Number Presented Annually: 3 total

Presentation: PharmSci 360

Award: Acknowledgement during the PharmSci 360 opening session; highlighted in PharmSci 360 attendance materials, such as the mobile app; an invitation to present the winning poster in a special poster collection.

Expectations for Recipient: Participation in PharmSci 360 poster program in year of receipt; presentation of poster at times scheduled by AAPS.

Nomination Type: AAPS will automatically identify candidates from the AAPS Best Abstract Award recipients. Candidates do not complete an application form.

Qualifications for Nomination:

  • Must be an AAPS member at time of poster submission
  • Must be the presenting author of the poster
  • Poster must be submitted by deadline according to the submission process AAPS requires for poster authors

Selection Committee: The Abstract Screening Committee reviews and recommends posters for consideration to the Scientific Advisory Committee, which selects three recipients. Candidates do not complete an application form.

Past Recipients 

2024
Jiahui Li, Pharm.D.
Development of a New Modality with Strong Cancer Immunotherapeutic Effect (CITE) for Multiple Myeloma Treatment (T1530-04-21)

Kasturi Siddhanta, MS
Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors (M1230-01-06)

Shannuo Li, MS
Novel Personalized Treatment for Multiple Myeloma: Multi-Antigen T Cell Hybridizers for T Cell Activation (M1230-04-22)

2023

Aishwarya Saraswat

Novel Gene Therapy for Drug-Resistant Melanoma: Synergistic Combination of PTEN Plasmid and BRD4 PROTAC Loaded Lipid Nanocarriers (#T1230-11-74)

Neetu Singh

Ultrasmall Nanoprobes for Fluorescence-Guided Surgical Resection of Peritoneally Disseminated Tumors (#M1230-10-68)

Richa Vartak

Cetuximab-Based Proteolysis Targeting Chimera for Effectual Downregulation of NSCLC with Varied EGFR Mutations (#M1230-06-40)

2022

Zachary Greenberg

 An End-to-End Method for AI-Driven Peptide Vaccine Formulation and Translation through Deep Learned Exosome Precision Drug Delivery (T0930-10-56)

Raja Reddy Kallem

A Targeted LC-MS/MS Method for Quantitative Tissue Distribution Analysis (QTDA) of Metabolomics in Tumors using Laser Microdissection (T1430-09-54)

Yi-En Liao

Modulating Host Response to Sepsis via Pure Anti-inflammatory Heparin-Like Compounds (W0930-10-58)

2021

Tu Van Duong

Surface Nanocoating of High Drug-Loading Spray-Dried Amorphous Solid Dispersions by Atomic Layer Deposition: Excellent Physical Stability under Accelerated Conditions for More Than a Year (T0930-04-20)

Zachary Greenberg

An End-to-End Artificial Peptide-to-Receptor Targeting Strategy to Develop Exosome Homing Ability for Precision Drug Delivery (T1030-01-03)

Xiaoqi Sun

Novel Cancer Immunotherapy by Amplifying Immune Response with Nutritional Metal Ions (W4115V)

2019 

Michele Herneise

Adapting Quality by Design Approaches to Microemulsions as a Model Nanoformulation to Improve Process Understanding and Facilitate Scale-Up (M1130-08-50) 

Ali Keshavarz

Circulating Endothelial Cells (CECs) as a Diagnostic and Prognostic Marker for Pulmonary Arterial Hypertension (PAH): A Proof of Concept Study in PAH Patients (T0930-13-83)

Lindsay Scheetz

Synthetic High-Density Lipoprotein Nanodiscs for Personalized Vaccination against Glioblastoma Multiforme (M1430-02-08)